Sponsored
MCD beats Q1 estimates with 9.4% revenue growth & 3.1% EPS beat. Value menu drives gains amid inflation.
RXO beats revenue estimates on flat sales; AI & contract gains boost Q2 EBITDA outlook.
BGC's revenue surges 44.3% but Q2 guidance misses; EPS in line. Valuation metrics to watch.
MELI revenue up 46%, but margins dip to 6.9% on investments. P/E near 40, risks priced in?
MEOH surged 95% but faces risks; PCJ liquidates $10.5M amid net loss.
April CPI likely up 0.6%, annual inflation hits 3.7%. Fed rates steady, oil prices fuel costs.
EL beats EPS estimates, raises guidance. Fragrance & China drive growth, but margins dip. Buy?
Sponsored